Imugene Stock Quote IMU - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.049

Bid

0.048

Ask

0.049

Volume

7,853,209

0.048 Day's Range 0.05

0.039 52 Week Range 0.15

Market Cap

358.671M

Previous Close

0.05

Open

0.05

Last Trade

0.048

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

21,387,555

Shares Outstanding

7,319,810,809

Dividend Yield

PE Ratio

-2.45

Earnings Per Share (EPS)

-0.02

Revenue

4.97M

Net Profit

-149.68M

Sector

Biological Pds,ex Diagnstics

Industry

Biotechnology Animal & Plant

Website

www.imugene.com

Headquarters

Melbourne, Victoria, Aus

Founded

1986

Imugene Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker IMU. The last closing price for Imugene was AUD0.05. Over the last year, Imugene shares have traded in a share price range of AUD 0.039 to AUD 0.15.

Imugene currently has 7,319,810,809 shares outstanding. The market capitalization of Imugene is AUD365.99 million. Imugene has a price to earnings ratio (PE ratio) of -2.45.

RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform

Collaboration will explore trans-arterial delivery of Imugene’s CF33 oncolytic virus utilizing RenovoRx’s TAMP therapy platform. TAMP is expected to enable localized, targeted delivery of CF33...

Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer

New clinical trial supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.Avelumab (BAVENCIO®) to be provided to Imugene for Phase 2 clinical study in HER-2 positive gastric or...

Imugene and Eureka Therapeutics Announce Strategic Collaboration to Accelerate Advancement of Oncolytic Virus and T-Cell Therapy in Solid Tumours

The Collaboration will evaluate Eureka’s anti-CD19 ARTEMIS® T-cell therapy in combination with Imugene’s CD19-expressing oncolytic virus onCARlytics in solid tumours Potential to address lack of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.001	-2	0.05	0.051	0.047	17970798	0.04907059	DE
4	-0.012	-19.6721311475	0.061	0.063	0.047	26625554	0.05180766	DE
12	-0.002	-3.92156862745	0.051	0.081	0.047	21387555	0.05612705	DE
26	-0.056	-53.3333333333	0.105	0.1125	0.047	21893943	0.06433775	DE
52	0.002	4.25531914894	0.047	0.15	0.039	28139613	0.08058223	DE
156	-0.421	-89.5744680851	0.47	0.625	0.039	23033019	0.1641664	DE
260	0.027	122.727272727	0.022	0.625	0.016	22254387	0.16066263	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
QEMRQEM Limited	AUD 0.019 (72.73%)	526.34k
PFEOPantera Minerals Ltd	AUD 0.005 (66.67%)	885.72k
ILAOIsland Pharmaceuticals Limited	AUD 0.04 (53.85%)	2.74M
ERLEmpire Resources Limited	AUD 0.003 (50.00%)	1.59M
AUZOAAustralian Mines Ltd	AUD 0.003 (50.00%)	250k
INPIncentiaPay Limited	AUD 0.003 (-40.00%)	60.99k
NRXONoronex Limited	AUD 0.003 (-40.00%)	2M
IMIInfinity Mining Ltd	AUD 0.031 (-27.91%)	401.86k
ALRAltair Minerals Ltd	AUD 0.003 (-25.00%)	12.54M
XGLXamble Group Limited	AUD 0.022 (-21.43%)	505.04k
PLSPilbara Minerals Limited	AUD 3.16 (-4.82%)	121.38M
FHEFrontier Energy Ltd	AUD 0.11 (-8.33%)	46.49M
PECPerpetual Resources Ltd	AUD 0.012 (0.00%)	36.13M
SIGSigma Healthcare Limited	AUD 2.05 (7.05%)	34.77M
SYASayona Mining Limited	AUD 0.032 (-8.57%)	31.81M